Sort
16,179 grants matching “malaria”
Placental Colonization by Treponema Pallidum, Congenital Syphilis & Novel Vaccine
$659,423Nikhat Parveen · Rbhs-New Jersey Medical School · U01 · FY2017 · AI
Optimizing strategies for malaria surveillance and measuring the impact of contro
$659,314Moses Robert Kamya · University Of California, San Francisco · U19 · FY2013 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$659,272Gillian L Beamer · Tufts University Boston · R01 · FY2022 · HL
Development of a topical malaria vaccine.
$658,790Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2017 · AI
Effector and regulatory T cell responses and protection from clinical malaria
$658,721Margaret E Feeney · University Of California, San Francisco · R01 · FY2017 · AI
MicroRNA regulation of Anopheles immunity to Plasmodium
$658,651Jinsong Zhu · Virginia Polytechnic Inst And St Univ · R01 · FY2019 · AI
Vector-Borne Diseases: Molecular Mechanisms in Vector-Host Interactions
$658,614Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
An.gambiae immune signaling gene SNPs and natural P. falciparum infection
$658,558Shirley Luckhart · University Of California At Davis · R01 · FY2011 · AI
Targeted Vaccine Development for Pediatric Falciparum Malaria
$658,205Jonathan D. Kurtis · Rhode Island Hospital · R01 · FY2010 · AI
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
$658,058Jagpreet Chhatwal · Massachusetts General Hospital · · FY2017 · CSE
Effect of genomic imprinting in placentas on maternal transmission of growth phenotypes to offspring in a multigenerational human cohort study
$658,017Beverly Ilse Strassmann · University Of Michigan At Ann Arbor · R01 · FY2023 · HD
Effect of genomic imprinting in placentas on maternal transmission of growth phenotypes to offspring in a multigenerational human cohort study
$657,916Beverly Ilse Strassmann · University Of Michigan At Ann Arbor · R01 · FY2022 · HD
Malaria Vaccine Trials in Mali
$657,867University Of Maryland Baltimore · U19 · FY2005 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$657,610Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$657,600Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2020 · AI
Olfactory modulation of color vision and behavior in mosquitoes
$657,511Jeffrey A Riffell · University Of Washington · R01 · FY2023 · AI
Antimalarial drug resistance in P. falciparum
$657,480Liwang Cui · University Of South Florida · U19 · FY2020 · AI
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$657,385Amy Kristine Bei · Yale University · R01 · FY2024 · AI
Exploring the roles of acquired immunity and functional constraint in sculpting malaria antigenic diversity in a longitudinal cohort
$657,223Daniel E Neafsey · Harvard School Of Public Health · R01 · FY2019 · AI
Optimizing HIV-malaria treatment in a shifting treatment and resistance landscape in Africa
$656,987Sunil Parikh · Yale University · R01 · FY2025 · HD
Genetic Variation and Evolution of Artemisinin Resistance
$656,975Dyann F Wirth · Harvard School Of Public Health · R01 · FY2013 · AI
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda
$656,831Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2024 · AI
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda
$656,831Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2023 · AI
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda
$656,831Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2022 · AI
Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda
$656,718Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2021 · AI